The impact of glycolysis on ischemic stroke: from molecular mechanisms to clinical applications
Ischemic stroke (IS), a leading cause of disability and mortality worldwide, remains a significant challenge due to its complex pathogenesis. Glycolysis, a central metabolic pathway, plays a critical role in bridging the gap between metabolic dysfunction and neurological impairment. During ischemic...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1514394/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832589941230534656 |
|---|---|
| author | Yingquan Liu Peijia Hu Hongliang Cheng Fangyuan Xu Yu Ye |
| author_facet | Yingquan Liu Peijia Hu Hongliang Cheng Fangyuan Xu Yu Ye |
| author_sort | Yingquan Liu |
| collection | DOAJ |
| description | Ischemic stroke (IS), a leading cause of disability and mortality worldwide, remains a significant challenge due to its complex pathogenesis. Glycolysis, a central metabolic pathway, plays a critical role in bridging the gap between metabolic dysfunction and neurological impairment. During ischemic conditions, glycolysis replaces oxidative phosphorylation as the primary energy source for brain tissue. However, in the ischemia–reperfusion state, neuronal cells show a particular reliance on aerobic glycolysis. Immune cells, such as monocytes, also contribute to atheromatous plaque formation and thrombi through increased aerobic glycolysis. Given glycolysis’s involvement in various pathological stages of IS, it offers the potential for improved diagnosis, treatment, and prevention. This review comprehensively explores the role of glycolysis in different phases of IS, addresses existing controversies, and discusses its diagnostic and therapeutic applications. By elucidating the intricate relationship between glycolysis and IS, this review aims to provide novel insights for future research and clinical advancements. |
| format | Article |
| id | doaj-art-d33cf823530b42208da3ab25c85ac9ca |
| institution | Kabale University |
| issn | 1664-2295 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Neurology |
| spelling | doaj-art-d33cf823530b42208da3ab25c85ac9ca2025-01-24T05:21:22ZengFrontiers Media S.A.Frontiers in Neurology1664-22952025-01-011610.3389/fneur.2025.15143941514394The impact of glycolysis on ischemic stroke: from molecular mechanisms to clinical applicationsYingquan Liu0Peijia Hu1Hongliang Cheng2Fangyuan Xu3Yu Ye4The First Clinical College of Anhui University of Chinese Medicine, Hefei, ChinaThe Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, ChinaThe Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, ChinaThe First Clinical College of Anhui University of Chinese Medicine, Hefei, ChinaGraduate School, Anhui University of Chinese Medicine, Hefei, Anhui, ChinaIschemic stroke (IS), a leading cause of disability and mortality worldwide, remains a significant challenge due to its complex pathogenesis. Glycolysis, a central metabolic pathway, plays a critical role in bridging the gap between metabolic dysfunction and neurological impairment. During ischemic conditions, glycolysis replaces oxidative phosphorylation as the primary energy source for brain tissue. However, in the ischemia–reperfusion state, neuronal cells show a particular reliance on aerobic glycolysis. Immune cells, such as monocytes, also contribute to atheromatous plaque formation and thrombi through increased aerobic glycolysis. Given glycolysis’s involvement in various pathological stages of IS, it offers the potential for improved diagnosis, treatment, and prevention. This review comprehensively explores the role of glycolysis in different phases of IS, addresses existing controversies, and discusses its diagnostic and therapeutic applications. By elucidating the intricate relationship between glycolysis and IS, this review aims to provide novel insights for future research and clinical advancements.https://www.frontiersin.org/articles/10.3389/fneur.2025.1514394/fullischemic strokeglycolysisglucose metabolismpathomechanismdiagnosistreatment |
| spellingShingle | Yingquan Liu Peijia Hu Hongliang Cheng Fangyuan Xu Yu Ye The impact of glycolysis on ischemic stroke: from molecular mechanisms to clinical applications Frontiers in Neurology ischemic stroke glycolysis glucose metabolism pathomechanism diagnosis treatment |
| title | The impact of glycolysis on ischemic stroke: from molecular mechanisms to clinical applications |
| title_full | The impact of glycolysis on ischemic stroke: from molecular mechanisms to clinical applications |
| title_fullStr | The impact of glycolysis on ischemic stroke: from molecular mechanisms to clinical applications |
| title_full_unstemmed | The impact of glycolysis on ischemic stroke: from molecular mechanisms to clinical applications |
| title_short | The impact of glycolysis on ischemic stroke: from molecular mechanisms to clinical applications |
| title_sort | impact of glycolysis on ischemic stroke from molecular mechanisms to clinical applications |
| topic | ischemic stroke glycolysis glucose metabolism pathomechanism diagnosis treatment |
| url | https://www.frontiersin.org/articles/10.3389/fneur.2025.1514394/full |
| work_keys_str_mv | AT yingquanliu theimpactofglycolysisonischemicstrokefrommolecularmechanismstoclinicalapplications AT peijiahu theimpactofglycolysisonischemicstrokefrommolecularmechanismstoclinicalapplications AT hongliangcheng theimpactofglycolysisonischemicstrokefrommolecularmechanismstoclinicalapplications AT fangyuanxu theimpactofglycolysisonischemicstrokefrommolecularmechanismstoclinicalapplications AT yuye theimpactofglycolysisonischemicstrokefrommolecularmechanismstoclinicalapplications AT yingquanliu impactofglycolysisonischemicstrokefrommolecularmechanismstoclinicalapplications AT peijiahu impactofglycolysisonischemicstrokefrommolecularmechanismstoclinicalapplications AT hongliangcheng impactofglycolysisonischemicstrokefrommolecularmechanismstoclinicalapplications AT fangyuanxu impactofglycolysisonischemicstrokefrommolecularmechanismstoclinicalapplications AT yuye impactofglycolysisonischemicstrokefrommolecularmechanismstoclinicalapplications |